Cargando…
“γδT Cell-IL17A-Neutrophil” Axis Drives Immunosuppression and Confers Breast Cancer Resistance to High-Dose Anti-VEGFR2 Therapy
Angiogenesis is an essential physiological process and hallmark of cancer. Currently, antiangiogenic therapy, mostly targeting the vascular endothelial growth factor (VEGF)/VEGFR2 signaling axis, is commonly used in the clinic for solid tumors. However, antiangiogenic therapies for breast cancer pat...
Autores principales: | Zhang, Zhigang, Yang, Chenghui, Li, Lili, Zhu, Ying, Su, Ke, Zhai, Lingyun, Wang, Zhen, Huang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554133/ https://www.ncbi.nlm.nih.gov/pubmed/34721375 http://dx.doi.org/10.3389/fimmu.2021.699478 |
Ejemplares similares
-
γδIL17 under control
por: Sanchez Sanchez, Guillem, et al.
Publicado: (2022) -
IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
por: Coffelt, Seth B., et al.
Publicado: (2015) -
Tumor-associated neutrophils suppress pro-tumoral IL-17+ γδ T cells through induction of oxidative stress
por: Mensurado, Sofia, et al.
Publicado: (2018) -
Deleterious Effect of the IL-23/IL-17A Axis and
γδT Cells on Left Ventricular Remodeling After Myocardial
Infarction
por: Yan, Xiaoxiang, et al.
Publicado: (2012) -
IL‐23 drives differentiation of peripheral γδ17 T cells from adult bone marrow‐derived precursors
por: Papotto, Pedro H, et al.
Publicado: (2017)